Tirzepatide is a novel dual GIP and GLP-1 receptor agonist developed for research applications. This synthetic peptide demonstrates superior stability and biological activity, making it valuable for metabolic disorder studies.
Our facility produces tirzepatide under strict GMP conditions, ensuring batch-to-batch consistency and the highest purity standards. The product undergoes rigorous quality control testing including HPLC, MS, and amino acid analysis to verify identity and purity.
Available in multiple packaging configurations to meet various research needs, our tirzepatide prices remain competitive without compromising quality. We offer flexible quantities from small batches to bulk orders, with options for custom formulations upon request.
The product is supplied as a lyophilized powder in sterile vials with appropriate documentation including Certificate of Analysis. Proper storage at -20°C is recommended to maintain stability.
Important Note: This product is intended for research purposes only. Not for human or veterinary use. Researchers should handle all materials according to laboratory safety protocols.